These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37222698)

  • 1. Colorectal cancer: Review of signaling pathways and associated therapeutic strategies.
    Leiphrakpam PD; Rajappa SJ; Krishnan M; Batra R; Murthy SS; Are C
    J Surg Oncol; 2023 Jun; 127(8):1277-1295. PubMed ID: 37222698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development.
    Li X; Wu Y; Tian T
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments.
    Tang YL; Li DD; Duan JY; Sheng LM; Wang X
    World J Gastroenterol; 2023 Feb; 29(6):926-948. PubMed ID: 36844139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatment for metastatic colorectal cancer.
    Leowattana W; Leowattana P; Leowattana T
    World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay.
    Fan X; Meng M; Li B; Chen H; Tan J; Xu K; Xiao S; Kwan HY; Liu Z; Su T
    J Transl Med; 2023 Apr; 21(1):260. PubMed ID: 37062842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Targeted Therapy for Metastatic Colorectal Cancer.
    Ohishi T; Kaneko MK; Yoshida Y; Takashima A; Kato Y; Kawada M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer.
    Rodriquenz MG; Ciardiello D; Latiano TP; Maiorano BA; Martinelli E; Silvestris N; Ciardiello F; Maiello E
    Crit Rev Oncol Hematol; 2022 May; 173():103657. PubMed ID: 35337969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer.
    Xu X; Liu M; Peng K; Yu Y; Liu T
    Clin Transl Oncol; 2023 Mar; 25(3):776-785. PubMed ID: 36609651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of metastatic colorectal cancer in the era of precision medicine.
    Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
    CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge.
    Scheurlen KM; Billeter AT; O'Brien SJ; Galandiuk S
    Cancer Med; 2020 Sep; 9(18):6679-6693. PubMed ID: 33624450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review.
    Vaghi C; Mauri G; Agostara AG; Patelli G; Pizzutilo EG; Nakamura Y; Yoshino T; Siena S; Sartore-Bianchi A
    Cancer Treat Rev; 2023 Jan; 112():102488. PubMed ID: 36410093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond Targeted Therapies in Colon Cancer Today and Tomorrow.
    Pohl M; Schmiegel W
    Dig Dis; 2016; 34(5):574-9. PubMed ID: 27332557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastatic colorectal cancer-Modern treatment strategies and sequences].
    Ettrich TJ; Schuhbaur JS; Seufferlein T
    Inn Med (Heidelb); 2023 Jun; 64(6):546-559. PubMed ID: 37222756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
    Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA
    Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tumor location and survival among metastatic colorectal cancer patients treated with systemic chemotherapy and biologic therapies: Retrospective analysis.
    Ramadan M; Alfayea T; Alsofyani A; Alyabsi M; Alhusseini N; Algarni AS
    Cancer Treat Res Commun; 2022; 33():100632. PubMed ID: 36088745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer.
    Ciombor KK; Bekaii-Saab T
    Oncologist; 2018 Jan; 23(1):25-34. PubMed ID: 29021377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer.
    Cruz-Duarte R; Rebelo de Almeida C; Negrão M; Fernandes A; Borralho P; Sobral D; Gallego-Paez LM; Machado D; Gramaça J; Vílchez J; Xavier AT; Ferreira MG; Miranda AR; Mansinho H; Brito MJ; Pacheco TR; Abreu C; Lucia-Costa A; Mansinho A; Fior R; Costa L; Martins M
    Clin Cancer Res; 2022 Mar; 28(6):1203-1216. PubMed ID: 34980600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer.
    Nakamura Y; Yoshino T
    Oncologist; 2018 Nov; 23(11):1310-1318. PubMed ID: 29700206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of heat shock proteins in metastatic colorectal cancer: A review.
    Javid H; Hashemian P; Yazdani S; Sharbaf Mashhad A; Karimi-Shahri M
    J Cell Biochem; 2022 Nov; 123(11):1704-1735. PubMed ID: 36063530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
    Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
    World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.